Beyer-Westendorf J, Bauersachs R, Hach-wenderle V, et al. Sex hormones and venous thromboembolism-from contraception to hoemone replacement therapy. Vasa 2018;47:441-50.
Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-12.
Sweetland S, Beral V, Balkwill A, et al. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J Thromb Haemost 2012;10:2277-86.
Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-13.
In order to continuously optimize website functionality and user experience, this website uses cookies analysis technology for website operation, analysis, and personalized services.
If you continue to browse this website, it means you agree to the use of cookies on this website.